279 related articles for article (PubMed ID: 16198480)
1. Receptor protection studies comparing recombinant and native nicotinic receptors: Evidence for a subpopulation of mecamylamine-sensitive native alpha3beta4* nicotinic receptors.
Free RB; Kaser DJ; Boyd RT; McKay DB
Neurosci Lett; 2006 Jan; 392(1-2):135-9. PubMed ID: 16198480
[TBL] [Abstract][Full Text] [Related]
2. AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.
Toll L; Zaveri NT; Polgar WE; Jiang F; Khroyan TV; Zhou W; Xie XS; Stauber GB; Costello MR; Leslie FM
Neuropsychopharmacology; 2012 May; 37(6):1367-76. PubMed ID: 22278092
[TBL] [Abstract][Full Text] [Related]
3. [3H]Epibatidine binding to bovine adrenal medulla: evidence for alpha3beta4* nicotinic receptors.
Free RB; Bryant DL; McKay SB; Kaser DJ; McKay DB
Neurosci Lett; 2002 Jan; 318(2):98-102. PubMed ID: 11796195
[TBL] [Abstract][Full Text] [Related]
4. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
de Moura FB; McMahon LR
Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
[TBL] [Abstract][Full Text] [Related]
5. Conformational mobility of immobilized alpha3beta2, alpha3beta4, alpha4beta2, and alpha4beta4 nicotinic acetylcholine receptors.
Moaddel R; Jozwiak K; Whittington K; Wainer IW
Anal Chem; 2005 Feb; 77(3):895-901. PubMed ID: 15679359
[TBL] [Abstract][Full Text] [Related]
6. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
[TBL] [Abstract][Full Text] [Related]
7. Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice.
Marks MJ; Whiteaker P; Grady SR; Picciotto MR; McIntosh JM; Collins AC
J Neurochem; 2002 Jun; 81(5):1102-15. PubMed ID: 12065623
[TBL] [Abstract][Full Text] [Related]
8. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of recombinant bovine alpha3beta4 neuronal nicotinic receptors stably expressed in HEK 293 cells.
Free RB; von Fischer ND; Boyd RT; McKay DB
Neurosci Lett; 2003 Jun; 343(3):180-4. PubMed ID: 12770692
[TBL] [Abstract][Full Text] [Related]
10. Receptor protection studies to characterize neuronal nicotinic receptors: tubocurarine prevents alkylation of adrenal nicotinic receptors.
Free RB; McKay DB
Brain Res; 2001 Feb; 891(1-2):176-84. PubMed ID: 11164821
[TBL] [Abstract][Full Text] [Related]
11. Effect of novel negative allosteric modulators of neuronal nicotinic receptors on cells expressing native and recombinant nicotinic receptors: implications for drug discovery.
González-Cestari TF; Henderson BJ; Pavlovicz RE; McKay SB; El-Hajj RA; Pulipaka AB; Orac CM; Reed DD; Boyd RT; Zhu MX; Li C; Bergmeier SC; McKay DB
J Pharmacol Exp Ther; 2009 Feb; 328(2):504-15. PubMed ID: 18984653
[TBL] [Abstract][Full Text] [Related]
12. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor.
Talka R; Salminen O; Tuominen RK
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Nicotinic Receptor Subtypes in the Behavioral Effects of Nicotinic Drugs in Squirrel Monkeys.
Withey SL; Doyle MR; Bergman J; Desai RI
J Pharmacol Exp Ther; 2018 Aug; 366(2):397-409. PubMed ID: 29784663
[TBL] [Abstract][Full Text] [Related]
14. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors.
Gentry CL; Wilkins LH; Lukas RJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):206-16. PubMed ID: 12490593
[TBL] [Abstract][Full Text] [Related]
15. 3'-Fluoro substitution in the pyridine ring of epibatidine improves selectivity and efficacy for alpha4beta2 versus alpha3beta4 nAChRs.
Abdrakhmanova GR; Carroll FI; Damaj MI; Martin BR
Neuropharmacology; 2008 Dec; 55(8):1287-92. PubMed ID: 18775444
[TBL] [Abstract][Full Text] [Related]
16. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP.
Matsuyama S; Matsumoto A
J Pharmacol Sci; 2003 Oct; 93(2):180-7. PubMed ID: 14578586
[TBL] [Abstract][Full Text] [Related]
17. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
Xiao Y; Meyer EL; Thompson JM; Surin A; Wroblewski J; Kellar KJ
Mol Pharmacol; 1998 Aug; 54(2):322-33. PubMed ID: 9687574
[TBL] [Abstract][Full Text] [Related]
18. Surface and intracellular nicotinic receptors expressed in intact adrenal chromaffin cells: direct measurements using [3H]epibatidine.
Free RB; McKay DB
Brain Res; 2003 Jun; 974(1-2):60-9. PubMed ID: 12742624
[TBL] [Abstract][Full Text] [Related]
19. High affinity binding of epibatidine to serotonin type 3 receptors.
Drisdel RC; Sharp D; Henderson T; Hales TG; Green WN
J Biol Chem; 2008 Apr; 283(15):9659-65. PubMed ID: 17702741
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
